Design and Conduct Considerations for First‐in‐Human Trials
A milestone step in translational science to transform basic scientific discoveries into therapeutic applications is the advancement of a drug candidate from preclinical studies to initial human testing. First‐in‐human (FIH) trials serve as the link to advance new promising drug candidates and are c...
Main Authors: | Jie Shen, Brandon Swift, Richard Mamelok, Samuel Pine, John Sinclair, Mayssa Attar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12582 |
Similar Items
-
Considerations of trial design and conduct in behavioral interventions for the management of chronic pain in adults
by: Sara N. Edmond, et al.
Published: (2019-06-01) -
Considerations for using distributed research networks to conduct aspects of randomized trials
by: Keith A. Marsolo, et al.
Published: (2020-03-01) -
Key considerations for conducting Chinese medicine clinical trials in hospitals
by: Shergis Johannah L, et al.
Published: (2013-02-01) -
HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention.
by: Marie-Claude Boily, et al.
Published: (2012-01-01) -
Design considerations for clinical trials in aphasia
by: Rebecca Palmer
Published: (2020-01-01)